Cardiorenal syndrome encompasses a spectrum of disorders involving both the heart and
kidneys in which acute or chronic dysfunction in 1 organ may induce acute or chronic …

Introduction. Heart failure (HF) is highly prevalent in patients with chronic kidney disease
(CKD) and end‐stage renal disease (ESRD) and is strongly associated with mortality in …

Appropriate interpretation of changes in markers of kidney function is essential during the
treatment of acute and chronic heart failure. Historically, kidney function was primarily …

Novel pharmacologic treatment options reduce mortality and morbidity in a cost‐effective
manner in patients with heart failure (HF). Undisputedly, the effective implementation of …

Background: Patients with end-stage renal disease are known to have decreased survival
after myocardial infarction, but the association of less severe renal dysfunction with survival …

Background—The prognostic importance of renal insufficiency (RI) in patients undergoing
primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) has …

Objectives: This study was designed to examine the use of cardiovascular medications and
outcomes in patients with heart failure (HF) and renal dysfunction. Background: Renal …

Chronic kidney disease (CKD) is common and is associated with increased mortality in heart
failure (HF). However, it is unknown whether the effect of CKD on mortality varies by left …

Chronic renal failure is characterized by a persistently abnormal glomerular filtration rate.
The rate of progression varies substantially. Several morphologic features are prominent …

Clinical trials have demonstrated that angiotensin-converting enzyme (ACE) inhibitors,-
blockers, and spironolactone improve survival in patients with heart failure. Because …